Regarding the Humanigen phase 3 trial - I can't seem to find the total number of patients required for enrollment; anybody know? And do they get a 50 patient interim analysis like we do? I see that their trial patients must have pneumonia; so I am thinking that is more narrow than our class of severely ill patients; are my correct?